ProstaStream vs ProstaVive: Which Should You Buy? (2026)
A side-by-side look at ProstaStream and ProstaVive — formula, evidence, safety, price and who each actually suits. No affiliate links appear on our comparison pages.


Quick verdict
Neither is a substitute for a PSA test and examination, and that matters more than the comparison. On formula, both lean on saw palmetto, whose two largest independent trials — STEP and CAMUS — were negative. Beta-sitosterol has better data than either product's headline ingredient.
Neither is a treatment for any condition. If you take medication or have a health condition, check with a doctor before choosing either.
Side-by-side comparison
| Feature | ProstaStream | ProstaVive |
|---|---|---|
| Lead ingredient | Saw palmetto, plus a mushroom blend, pygeum, lycopene, zinc, selenium | See the ProstaVive review for its current panel |
| Evidence on the lead ingredient | STEP and CAMUS found no significant benefit over placebo, including at 960 mg | Same category-wide caveat applies |
| Better-evidenced alternative | Beta-sitosterol has stronger randomised support for urinary flow and symptom scores | Beta-sitosterol, same point |
| Screening implication | Symptom relief can delay a PSA test that would distinguish BPH from cancer | Identical concern |
| How to measure it | The IPSS symptom score, plus night-time bathroom trips | The IPSS symptom score |
| Editorial rating | See the ProstaStream review | See the ProstaVive review |
The saw palmetto problem
This is where the category's credibility is decided. The NIH-funded STEP trial found no benefit over placebo at 320 mg daily for BPH symptoms. The follow-up CAMUS trial escalated to 960 mg — triple the standard dose — and still found no significant difference. These are the largest and best-designed trials available. Earlier positive results came from smaller, frequently industry-funded studies, which is the pattern you would expect if the effect were not real.
What has better support
Beta-sitosterol has more consistent randomised evidence for urinary flow and symptom scores than saw palmetto. Pygeum africanum has moderate data. Zinc concentrates in prostate tissue but supplementing it has not been shown to help BPH, and high-dose zinc has been associated with worse outcomes in some prostate cancer research. Selenium failed to prevent prostate cancer in the large SELECT trial.
The point that outranks the comparison
Nocturia, weak stream and urgency are usually benign prostatic hyperplasia. They can also be prostate cancer, and symptoms alone cannot distinguish them. A PSA test and digital examination take minutes. A supplement that makes symptoms tolerable is capable of delaying that, and that is a real cost rather than a theoretical one.
Frequently asked questions
Which should I choose?
Neither before you have been assessed. After that, compare the disclosed doses against beta-sitosterol at 60–130 mg, which is the better-evidenced target.
How long before either would show anything?
Trials run 8–12 weeks. Track the IPSS score so you have something objective.
Do they shrink the prostate?
No. Neither has been shown to reduce prostate volume. 5-alpha reductase inhibitors do that; supplements do not.
Related on FactoWiki
General information, not medical advice. FactoWiki does not place affiliate links on comparison pages.